OGN

Organon & Co

US Healthcare Drug Manufacturers - General

Latest week
10 Jul 2026
Close
13.520000
Fair value
13.513290
Next-week expectancy
Undecided 54.29%
Sharemaestro

OGN Chart Pack

Organon & Co

Exchange
NYSE
Latest week
10 Jul 2026
Close
13.520000
Fair value
13.513290
Next-week expectancy
Undecided 54.29%
Generated
15 Jul 2026 23:15
Sector
Healthcare
Industry
Drug Manufacturers - General

Chart Summary

Over the latest 12 completed weeks ending 2026-07-10, OGN rose 20.25%, moving from 11.24 to 13.52. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 11 of the last 12 weeks. Relative Strength is 29.51 and has improved across the 12-week window. Market Dynamics is 0.95 on the latest week. Next-week expectancy is undecided at 54.29% based on similar historical setup states.

Key Points

Week Ending
10 Jul 2026
Latest Close
13.52
12-Week Change
20.25%
Trend Signal
Active
Next-Week Expectancy
Undecided 54.29%
Signal Weeks
11 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
29.51
Market Dynamics
0.95

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
10 Jul 2026
Latest Close
13.52
12-Week Change
20.25%
Trend Signal
Active
Next-Week Expectancy
Undecided 54.29%
Signal Weeks
11 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
29.51
Market Dynamics
0.95

Over the latest 12 completed weeks ending 2026-07-10, OGN rose 20.25%, moving from 11.24 to 13.52. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 11 of the last 12 weeks. Relative Strength is 29.51 and has improved across the 12-week window. Market Dynamics is 0.95 on the latest week. Next-week expectancy is undecided at 54.29% based on similar historical setup states.

Industry Peers

United States equities in Drug Manufacturers - General

Stock Exchange Week Open High Low Close Change
SCLX Scilex Holding Company NASDAQ 10 Jul 2026 7.68 10.43 7.01 9.48 23.44%
GRFS Grifols SA ADR NASDAQ 10 Jul 2026 7.14 7.32 7.05 7.27 1.82%
NVO Novo Nordisk A/S NYSE 10 Jul 2026 49.28 50.44 48.50 49.48 0.42%
SNY Sanofi ADR NASDAQ 10 Jul 2026 43.37 44.11 42.43 43.50 0.30%
PFE Pfizer Inc NYSE 10 Jul 2026 24.16 24.41 23.62 24.17 0.06%
BMY Bristol-Myers Squibb Company NYSE 10 Jul 2026 57.74 58.49 56.49 57.58 -0.28%
JNJ Johnson & Johnson NYSE 10 Jul 2026 260.23 269.43 255.52 256.98 -1.25%
LLY Eli Lilly and Company NYSE 10 Jul 2026 1208.00 1249.45 1178.32 1188.58 -1.61%
MIRA MIRA Pharmaceuticals, Inc. Common Stock NASDAQ 10 Jul 2026 0.94 0.99 0.90 0.92 -1.65%
GSK GlaxoSmithKline PLC ADR NYSE 10 Jul 2026 53.80 54.29 52.30 52.78 -1.90%
NVS Novartis AG ADR NYSE 10 Jul 2026 157.32 157.93 153.63 154.05 -2.08%
AMGN Amgen Inc NASDAQ 10 Jul 2026 371.70 375.25 359.47 363.39 -2.24%
GILD Gilead Sciences Inc NASDAQ 10 Jul 2026 132.88 137.70 127.88 129.83 -2.30%
MRK Merck & Company Inc NYSE 10 Jul 2026 129.31 130.00 122.90 123.54 -4.46%
ABBV AbbVie Inc NYSE 10 Jul 2026 259.92 260.92 245.05 248.08 -4.56%
MDCX Medicus Pharma Ltd. Common Stock NASDAQ 10 Jul 2026 0.43 0.47 0.40 0.41 -4.77%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.

Earnings vs Price

This view compares the weekly close with rolling TTM EPS. Both lines are indexed to 100 at the first visible week, so the chart shows whether price is moving faster or slower than earnings across the full chart window.

If rolling EPS rises faster than price, the gap is positive and the implied multiple has compressed. If price rises faster than rolling EPS, the gap is negative and the move is more dependent on multiple expansion.

Quarterly EPS points are shown as updates to the rolling earnings line. Use this alongside Trend Line, Fair Value, Market Dynamics, and Smart Money context.